The Diagnostic Imaging AI (artificial intelligence) focus page provides information, videos, podcasts, and the latest news about product developments, trial results, screening guidelines, and protocol guidance that touch on the development and use of AI across the healthcare continuum.
September 10th 2024
Developed with breast ultrasound data from nearly 1,200 women, a model with mixed radiomic and autoencoder features had a 90 percent AUC for diagnosing breast cancer, according to new research.
2023 ASCO Direct™ Highlights: Practice-Changing Data From the Leading Oncology Conference
View More
Satellite Symposia at the Annual Radiation Oncology Meeting
September 28-29, 2024
Register Now!
6th Annual Precision Medicine Symposium: An Illustrated Tumor Board
October 18-19, 2024
Register Now!
Community Practice Connections™: 24th Annual International Lung Cancer Congress®
View More
19th Annual New York Lung Cancers Symposium®
November 16, 2024
Register Now!
Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?
View More
Medical Crossfire®: How Do the Experts Select and Sequence Therapies to Optimize Patient Outcomes and Quality of Life in Advanced Prostate Cancer?
View More
Lung Cancer Tumor Board®: Enhancing Multidisciplinary Communication to Optimize Immunotherapy in Stage I-III NSCLC
View More
Clinical Vignettes™: The Experts Explain How They Integrate PET Imaging into Metastatic HR+ Breast Cancer Care Settings
View More
School of Breast Oncology® Live Video Webcast: Clinical Updates from San Antonio
View More
Annual Hawaii Cancer Conference
January 25-26, 2025
Register Now!
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Community Practice Connections™: The 2nd Annual Hawaii Lung Cancers Conference®
View More
18th Annual New York GU Cancers Congress™
March 28-29, 2025
Register Now!
Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®
View More
Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?
View More
Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?
View More
26th Annual International Lung Cancer Congress®
July 24-26, 2025
Register Now!
Enhancing MRI Efficiency and Quality: Can the New SIGNA Experience Have an Impact?
November 29th 2022Recently launched at the Radiological Society of North America (RSNA) conference, the SIGNA Experience reportedly features synergistic technologies and artificial intelligence (AI) advances that help improve the efficiency and quality of magnetic resonance imaging.
Deep Learning Model Predicts 10-Year Cardiovascular Disease Risk from Chest X-Rays
November 29th 2022Based on a single existing chest X-ray image, the deep learning model predicts future major adverse cardiovascular events with similar performance to an established risk scoring system and may help identify people for preventive use of statin medication.
Current Insights on AI, Breast Cancer Screening and the FDA
November 8th 2022In a recently published article, researchers from Yale University discuss the pros and cons of current FDA regulations as they apply to the clearance and use of adjunctive artificial intelligence (AI) software with conventional breast cancer screening modalities such as mammography.
Deep Learning Improves CT Guidance for Revascularization of Coronary Total Occlusions
October 31st 2022Emerging research revealed that a deep learning model had a nearly twofold increase in successful segmentation and reconstruction of coronary total occlusions (CTOs) on coronary computed tomography angiogram (CCTA) and a 73 percent reduction in post-processing and measurement time in comparison to a conventional manual approach.
Can AI-Powered Virtual Biopsies Improve Detection of Breast Lesion Subtypes on Digital Mammography?
October 27th 2022In separate test sets of Israeli women and United States women who had either ductal carcinoma in situ or invasive breast cancer, emerging artificial intelligence (AI) algorithms achieved an area under the curve (AOC) of 88 percent and 80 percent, respectively, for malignancy detection.
Philips Gets FDA Nod for MRI Head and Neck Radiotherapy Application
October 20th 2022For physicians performing radiotherapy treatment of soft tissue tumors in the head and neck, the MRCAT Head and Neck offers an artificial intelligence (AI) application that allows the use of magnetic resonance imaging (MRI) as the primary or sole imaging for procedure planning.
HeartFlow Garners FDA Clearances for Two AI-Powered Assessment Tools with CCTA
October 20th 2022Plaque Analysis and RoadMap Analysis, two artificial intelligence (AI)-enabled assessment products, may enhance clinical evaluation of coronary artery disease (CAD) on cardiac computed tomography angiography (CCTA).
What Would the Perfect AI Do for This Radiologist?
October 10th 2022While artificial intelligence (AI) models have been acknowledged for aiding imaging analysis or facilitating workflow enhancements, this author envisions AI as a potential workstation conceierge capable of turning common venting and gripes into actionable items for significant improvements.
Adjunctive AI Software for Brain MRI Gets FDA Clearance for Assessing High-Grade Gliomas
October 10th 2022Incorporating artificial intelligence (AI)-based technology, Neosoma HGG reportedly demonstrated a 95.5 percent accuracy rate in measuring brain tumor volume on brain magnetic resonance imaging (MRI) scans at various points during the treatment of patients with high-grade gliomas.
Flash Versus Function: Does the AI Focus in Radiology Compromise Our Infrastructure Needs?
October 3rd 2022Addressing upgrades of traditional infrastructure used in everyday radiology practice may be a more practical use of resources than investment in artificial intelligence (AI) technology that is still evolving.
MRI Deep Learning Software from GE Healthcare Gets Expanded FDA Clearance
September 29th 2022AIR Recon DL, a deep learning-based image reconstruction software, will now be available with 3D sequences as well as PROPELLER motion-insensitive sequences on magnetic resonance imaging (MRI) scanners from GE Healthcare.
Could a New Deep Learning Tool Enhance CT Detection of Pancreatic Cancer?
September 13th 2022New research reveals that an emerging deep learning tool had comparable sensitivity and specificity to radiologist assessment of contrast-enhanced computed tomography (CT) scans for pancreatic cancer, and a 74.7 percent sensitivity rate for tumors smaller than 2 cm.
CT AI Software for Fracture Risk Gets Breakthrough Device Designation from FDA
September 13th 2022Assessing high-resolution computed tomography (CT) scans of the wrist, CurveBeam AI’s OssView software reportedly enables clinicians to ascertain bone fragility and fracture risk for women over the age of 70.
Samsung Gets FDA Nod for Versatile V7 Ultrasound System
September 9th 2022Offering uniform high-resolution images through a combination of beamforming and enhanced image processing, the new ultrasound platform reportedly has an array of diagnostic features ranging from cardiovascular applications to breast lesion assessment.
Study: Deep Learning System is Comparable to Radiologist Assessment of Chest X-Rays for Tuberculosis
September 7th 2022Examining imaging data of patients from multiple countries, researchers found that a deep learning system demonstrated higher sensitivity and non-inferior specificity for detecting active tuberculosis on chest radiographs in comparison to nine radiologist reviewers.
Emerging AI CT Tool May Provide Viable Complement to Lung-RADS Classification
September 6th 2022Researchers suggest that an artificial intelligence (AI)-powered risk stratification tool for lung nodules identified on computed tomography (CT) scans may identify likely malignancies more than one year prior to definitive diagnosis.